Results 181 to 190 of about 16,846 (200)

SpliceUp: Predicting SF3B1 mutations in individual cells via aberrant splice site activation from scRNA-seq data

Kholmatov M, Prummel KD, Guezguez B, Hellström-Lindberg E, Moura PL, Zaugg JB.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Significance of SF3B1 Mutations in Myeloid Neoplasms

Clinics in Laboratory Medicine, 2023
Myelodysplastic neoplasm with low blasts and SF3B1 mutation (MDS-LB-SF3B1) has undergone significant classification changes in the past year with the publication of the 5th edition of the World Health Organization Classification of Tumors of Haematopoietic and Lymphoid Tissues and the International Consensus Classification.
David C, Gajzer, Cecilia C S, Yeung
openaire   +2 more sources

SF3B1in Chronic Lymphocytic Leukemia

New England Journal of Medicine, 2012
To the Editor: Wang et al. (Dec. 29 issue)1 report that SF3B1 mutation is associated with a shorter time to initiation of treatment in patients with chronic lymphocytic leukemia. However, this result should be interpreted with caution. In the discovery cohort of 91 patients, 29 were classified as having stage 0 disease, 43 as having stage I, and 19 as ...
Jinichi, Mori, Yukie, Takahashi, Tetsuya, Tanimoto   +2 more
openaire   +2 more sources

Chronic Lymphocytic Leukemia withSF3B1Mutation

New England Journal of Medicine, 2012
The authors found that chronic lymphocytic leukemia in patients with mutations in the SF3B1 RNA splicing gene has a more aggressive natural history than that in patients without such mutations.
Victor, Quesada, Andrew J, Ramsay, Carlos, Lopez-Otin   +2 more
openaire   +2 more sources

Role Of Sf3b1 On Hematopoiesis

Blood, 2013
Abstract Frequent pathway mutation involving multiple components of the RNA splicing machinery is a cardinal feature of myeloid neoplasms showing myeloid dysplasia, in which the major mutational targets include U2AF35, ZRSR2, SRSF2 and SF3B1.
Manabu Matsunawa, Ryo Yamamoto, Masashi Sanada, Aiko Sato, Yusuke Shiozawa, Kenichi Yoshida, Yasunobu Nagata, Ayana Kon, Tetsuichi Yoshizato, Makoto Otsu, Kyoichi Isono, Haruhiko Koseki, Hiromitsu Nakauchi, Seishi Ogawa   +13 more
openaire   +1 more source

Cancer-associated SF3B1 mutations inhibit mRNA nuclear export by disrupting SF3B1–THOC5 interactions

The Journal of Biochemistry
Abstract Mutations in SF3B1 are common in many types of cancer, promoting cancer progression through aberrant RNA splicing. Recently, mRNA nuclear export has been reported to be defective in cells with the SF3B1 K700E mutation. However, the mechanism remains unclear.
Gang Liu, Bo Zhao, Yueru Shi, Youzhong Wan   +3 more
openaire   +2 more sources

���������������������� ������ �������������� HEAT ���������������������� ������ ������������������ �������������������� SF3B1 ������ ���������������������� ������ ������

2017
SF3B1 is a highly conserved protein found in both the major and minor spliceosomes. It is part of the SF3b complex that, along with SF3a and the 12S snRNP, forms the functional 17S U2 snRNP. SF3B1 plays an important role in the recruitment, as well as the stabilization of the U2 snRNP at the branch site.
openaire   +1 more source

Abstract 4615: Influence of SF3B1 gene mutation is different from that of Sf3B1 inhibitor in colorectal cancer

Cancer Research, 2014
Abstract Purpose: We have reported that SF3B1 gene mutations are rare in colorectal cancer patients and SF3B1 gene mutations in codon 1074 are responsible for resistance to SF3B1 inhibitor (FR901464, FR) at the AACR annual meeting 2013. SF3B1 gene mutations in hematological malignancies are considered to be related to tumor progression ...
Tomoki Yamano, Shuji Kubo, Nagahide Matsubara, Aya Yano, Naohiro Tomita   +4 more
openaire   +1 more source

Abstract 4350: Low frequencies of SF3B1 mutations indicate SF3B1 inhibitor as a novel moleculartargeted drug for colorectal cancer.

Cancer Research, 2013
Abstract Purpose: FR901464 (FR) is an antitumor agent that specifically binds to and inhibits the function of splicing factor 3B subunit 1 (SF3B1). Higher frequencies of SF3B1 gene mutations and their relevance to cancer progression have been shown in studies of hematological malignancies.
Tomoki Yamano, Hidenori Nakajima, Satoshi Tsuda, Shuji Kubo, Mie Hamanaka, Masayoshi Kobayashi, Daisuke Yamagishi, Takashi Kuno, Kiyoshi Tsukamoto, Astuko Tamamoto, Masafumi Noda, Nagahide Matsubara, Dave SB Hoon, Naohiro Tomita   +13 more
openaire   +1 more source

Impact of SF3B1 mutation in myelofibrosis

Leukemia & Lymphoma, 2022
Jayastu Senapati, Srdan Verstovsek, Lucia Masarova, Naveen Pemmaraju, Keyur P. Patel, Guillermo Montalban-Bravo, Sherry A. Pierce, Lingsha Zhou, Guillermo Garcia-Manero, Hagop M. Kantarjian, Prithviraj Bose   +10 more
openaire   +2 more sources